Mettler-Toledo Sets 2027 Adjusted EPS Range at $52.50 to $53.50

Mettler-Toledo International Inc. projects 2027 adjusted EPS of $52.50 to $53.50, with 5% local-currency sales growth. China sales rose 13% in Q3, with mid-teens growth expected in Q4. The company cites risks from European economic conditions, inflation, and tariffs.

Original reporting
Published Nov 8, 2026, 6:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 8, 2026, 7:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Mettler-Toledo Sets 2027 Adjusted EPS Range at $52.50 to $53.50 — source image
Decision brief

The 30-second read

$MTDNeutralMed
01

Why it matters

The guidance provides the first forward‑looking EPS range for 2027, a key data point for valuation models.

02

Market read

First‑time 2027 guidance release offers fresh data for investors and analysts covering industrial equipment sector.

03

What to watch

Potential upside from mid‑single‑digit growth in China and pricing strength could mitigate pressure.

Relevance 8/10Novelty 8/10Timing: today

Background

Mettler-Toledo is a leading provider of precision instruments and weighing solutions, listed on NYSE.

Company-level read

Ticker impact

$MTDNeutralHigh confidence
Context

Mettler-Toledo International released its 2027 adjusted EPS guidance of $52.50‑$53.50 and sales growth outlook.

Expected impact

likely pressure as investors price in the modest EPS outlook

Evidence & confidence

The new EPS range is the first disclosure of 2027 guidance; traders will compare it to consensus estimates.

Market effects

Sets a benchmark for precision instrument makers, may influence peers' guidance expectations.

U.S. industrial equipment sector may see modest re‑rating.

Limited to markets tracking industrial equipment and manufacturing equipment stocks.

Counterpoint

If the guidance exceeds consensus, the stock could rally despite modest growth language.

Key entities

  • Mettler-Toledo International Inc.

    Provider of precision instruments and weighing solutions.

Related articles

$MTDHighAI 8/10

Biotech funding froze. Why has this lab instrument maker climbed 25% anyway?

Mettler-Toledo's stock rose 25% despite biotech funding freeze. Management's 2026 EPS guidance of $47.70-$47.90 exceeds consensus, with 2027 guidance also above expectations. Analysts' average price target is $1,590, but some, like Jefferies, raised targets to $1,930. The company expects $900M in free cash flow, supporting an $875M share buyback. Growth drivers include pharmacopeia revisions and GLP-1 manufacturing. Investors should evaluate service revenue and hardware cycles.

$MTDMed

Biotech funding froze. Why has this lab instrument maker climbed 25% anyway? By Investing.com RSS CTA

Mettler-Toledo International (MTD) has risen 25.2% in two months, defying a biotech funding slowdown. The company, a key supplier of precision lab instruments, benefits from regulatory requirements in commercial drug production. Q3 results showed $1.09B revenue, $12.57 adjusted EPS, and strong margins. Management's 2026-2027 EPS guidance exceeds Wall Street estimates, with free cash flow supporting share buybacks.

$MTDMedAI 8/10

What Mettler-Toledo International (MTD) Said on Its Q3 Earnings Call

Mettler-Toledo (MTD) reported Q3 gross margin expansion to 59.8% and adjusted operating profit growth of 8%. The company raised its 2026 sales growth forecast to 5% and issued 2027 guidance, expecting 5% sales growth and adjusted EPS of $52.50-$53.50. Management highlighted opportunities in automation, digitalization, and U.S. onshoring, with potential upside from AI-driven instrument upgrades.

$MTDMed

Jefferies raises Mettler-Toledo stock price target on solid growth

Jefferies raised its price target for Mettler-Toledo (MTD) to $1,930, citing strong Q3 results with 6% local currency growth and improved 2026 outlook. The stock trades near its 52-week high, up 26.5% in six months. MTD reported Q3 adjusted earnings of $12.57 per share and revenue of $1.09 billion, both exceeding estimates. The company provided initial 2027 guidance with 5% growth and EPS of $52.50-$53.50, above consensus.

$MTDHighAI 9/10

Mettler-Toledo (MTD) Q3 2026 Earnings Call Transcript

Mettler-Toledo (MTD) reported Q3 2026 sales of $1.1B, up 6% YoY, with organic growth in Asia (13%) and China (13%). Gross margin increased to 59.8%, and adjusted EPS rose 13% to $12.57. The company raised its 2026 sales growth forecast to 5% and expects 2027 sales growth of 5%, with adjusted EPS guidance of $52.50-$53.50, a 10-12% increase.